GlaxoSmithKline Award Lecture. The O-GlcNAc modification: three-dimensional structure, enzymology and the development of selective inhibitors to probe disease. (2010)

First Author: Davies GJ
Attributed to:  Studies of the O-GlcNAc Modification funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1042/bst0381179

PubMed Identifier: 20863281

Publication URI: http://europepmc.org/abstract/MED/20863281

Type: Journal Article/Review

Volume: 38

Parent Publication: Biochemical Society transactions

Issue: 5

ISSN: 0300-5127